Education
About Us
Working with TipRanks
Follow Us
Hydration Pharmaceuticals Co. Ltd. (AU:HPC)
ASX:HPC
Total Valuation
Hydration Pharmaceuticals Co. Ltd. has a market cap or net worth of AU$2.15M. The enterprise value is AU$402.68K.
Market CapAU$2.15M
Enterprise ValueAU$402.68K
Share Statistics
Hydration Pharmaceuticals Co. Ltd. has 430,800,930 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding430,800,930
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Hydration Pharmaceuticals Co. Ltd.’s return on equity (ROE) is -2.09 and return on invested capital (ROIC) is -229.32%.
Return on Equity (ROE)-2.09
Return on Assets (ROA)-1.35
Return on Invested Capital (ROIC)-229.32%
Return on Capital Employed (ROCE)-2.29
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover1.17
Inventory Turnover2.96
Valuation Ratios
The current PE Ratio of Hydration Pharmaceuticals Co. Ltd. is ―. Hydration Pharmaceuticals Co. Ltd.’s PEG ratio is 0.00320.
PE Ratio―
PS Ratio0.51
PB Ratio0.91
Price to Fair Value0.91
Price to FCF-0.34
Price to Operating Cash Flow-0.40
PEG Ratio0.00320
Income Statement
In the last 12 months, Hydration Pharmaceuticals Co. Ltd. had revenue of 2.56M and earned -2.96M in profits. Earnings per share was >-0.01.
Revenue2.56M
Gross Profit-27.42K
Operating Income-3.26M
Pretax Income-2.85M
Net Income-2.96M
EBITDA-3.26M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -3.78M and capital expenditures 0.00, giving a free cash flow of -3.78M billion.
Operating Cash Flow-3.78M
Free Cash Flow-3.78M
Free Cash Flow per Share>-0.01
Dividends & Yields
Hydration Pharmaceuticals Co. Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.35
52-Week Price Change0.00%
50-Day Moving Average0.01
200-Day Moving Average―
Relative Strength Index (RSI)45.82
Average Volume (3m)1.21M
Important Dates
Hydration Pharmaceuticals Co. Ltd. upcoming earnings date is Aug 27, 2026, Before Open (Confirmed).
Last Earnings DateMar 2, 2026
Next Earnings DateAug 27, 2026
Ex-Dividend Date―
Financial Position
Hydration Pharmaceuticals Co. Ltd. as a current ratio of 2.83, with Debt / Equity ratio of 0.00%
Current Ratio2.83
Quick Ratio1.70
Debt to Market Cap0.00
Net Debt to EBITDA0.34
Interest Coverage Ratio-43.70K
Taxes
In the past 12 months, Hydration Pharmaceuticals Co. Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Hydration Pharmaceuticals Co. Ltd. EV to EBITDA ratio is -0.05, with an EV/FCF ratio of -0.05.
EV to Sales0.07
EV to EBITDA-0.05
EV to Free Cash Flow-0.05
EV to Operating Cash Flow-0.05
Balance Sheet
Hydration Pharmaceuticals Co. Ltd. has AU$1.12M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of AU$1.12M billion.
Cash & Marketable SecuritiesAU$1.12M
Total DebtAU$0.00
Net CashAU$1.12M
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is 32.86%, with operating margin of -127.29%, and net profit margin of -115.74%.
Gross Margin32.86%
Operating Margin-127.29%
Pretax Margin-111.31%
Net Profit Margin-115.74%
EBITDA Margin-127.29%
EBIT Margin-127.29%
Analyst Forecast
The average price target for Hydration Pharmaceuticals Co. Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―